In addition, the uPAR-targeted optical imaging probes were developed and used in a mouse model of pancreatic cancer, where the nanoparticles were targeted for delivery and the imaging probes selectively aggregated at the edge of the tumor, allowing residual tumors to be detected by optical imaging (Yang et al., 2013). This evidence concerns the gene PLAUR and pancreatic neoplasm.